Algocell
Data-Driven Decisions for the Cell-Based Industry
Company Overview
Snapshot
Founded in March 2023 by David Almagor, Omri Schanin, and Eyal Betzalel, Algocell operates with 1–10 employees. The company has raised $2.8 million across three funding rounds from three investors. In July 2025, Algocell secured Pre-Seed funding from Good Company VC.
Business overview
Algocell is a Health Tech & Life Sciences company focused on enabling data-driven decisions for the cell-based industry. The company develops core technology in Simulation & Imaging, specifically leveraging Digital Twin technology to help bio-based product companies optimize cost, production volume, and product quality. Algocell's solutions aim to minimize resource usage, trial-and-error processes, and operate within the Pharma & Medical Biotechnology sector.
Log in to access full profile ›Company Intelligence Q&A
- What is Algocell's primary mission?
- Algocell's mission is to assist bio-based product companies in balancing cost, production volume, and product quality, while simultaneously minimizing resource consumption and reducing trial-and-error processes.
- When was Algocell founded and by whom?
- Algocell was founded in March 2023 by co-founders David Almagor, Omri Schanin, and Eyal Betzalel.
- What type of funding did Algocell receive in July 2025?
- In July 2025, Algocell secured Pre-Seed funding from Good Company VC.